These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16497244)

  • 1. Chromosomal numerical abnormalities in early stage lung adenocarcinoma.
    Sano T; Kitayama Y; Igarashi H; Suzuki M; Tanioka F; Chida K; Okudela K; Sugimura H
    Pathol Int; 2006 Mar; 56(3):117-25. PubMed ID: 16497244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.
    Yen CC; Liang SC; Jong YJ; Chen YJ; Lin CH; Chen YM; Wu YC; Su WC; Huang CY; Tseng SW; Whang-Peng J
    Lung Cancer; 2007 Sep; 57(3):292-301. PubMed ID: 17553591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
    Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
    Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma?
    Ullmann R; Bongiovanni M; Halbwedl I; Fraire AE; Cagle PT; Mori M; Papotti M; Popper HH
    J Pathol; 2003 Nov; 201(3):371-6. PubMed ID: 14595748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different vulnerability among chromosomes to numerical instability in gastric carcinogenesis: stage-dependent analysis by FISH with the use of microwave irradiation.
    Kitayama Y; Igarashi H; Sugimura H
    Clin Cancer Res; 2000 Aug; 6(8):3139-46. PubMed ID: 10955795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
    Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
    Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Urology; 1995 Dec; 46(6):837-42. PubMed ID: 7502426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between atypical adenomatous hyperplasia and primary lung cancer.
    Chapman AD; Kerr KM
    Br J Cancer; 2000 Sep; 83(5):632-6. PubMed ID: 10944604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
    Lantuéjoul S; Salameire D; Salon C; Brambilla E
    Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
    Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
    Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
    Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
    Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.
    Shen H; Gao W; Wu YJ; Qiu HR; Shu YQ
    Biomed Pharmacother; 2009 Jul; 63(6):396-403. PubMed ID: 18848758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.
    Sivakumar S; San Lucas FA; Jakubek YA; McDowell TL; Lang W; Kallsen N; Peyton S; Davies GE; Fukuoka J; Yatabe Y; Zhang J; Futreal PA; Fowler J; Fujimoto J; Ehli EA; Hawk ET; Wistuba II; Kadara H; Scheet P
    EBioMedicine; 2019 Apr; 42():296-303. PubMed ID: 30905849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study.
    Pelosi G; Del Curto B; Trubia M; Nicholson AG; Manzotti M; Veronesi G; Spaggiari L; Maisonneuve P; Pasini F; Terzi A; Iannucci A; Viale G
    Clin Cancer Res; 2007 Apr; 13(7):1995-2004. PubMed ID: 17404079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonrandom chromosomal numerical abnormality as a new molecular cytogenetic tumor marker--a retrospective study of 60 gastric cancer cases.
    Kitayama Y; Sugimura H
    Rinsho Byori; 2005 Oct; 53(10):881-6. PubMed ID: 16296333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung.
    Haneda H; Sasaki H; Shimizu S; Endo K; Suzuki E; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Lung Cancer; 2006 Apr; 52(1):47-52. PubMed ID: 16503085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
    Kim YT; Kim TY; Lee DS; Park SJ; Park JY; Seo SJ; Choi HS; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
    Lung Cancer; 2008 Jan; 59(1):111-8. PubMed ID: 17904685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.